Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Additional file 2: of Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo
Tsu-Yi Chao
(Contributor)
Peter M H Chang
(Creator)
Oluwaseun Adebayo Bamodu
(Contributor)
Wen Chien Huang
(Contributor)
Jia Hong Chen
(Creator)
Tse Hung Huang
(Contributor)
TMU Research Center of Cancer Translational Medicine
Taipei Medical University Shuang Ho Hospital
International Master/Ph.D. Program in Medicine
Department of Internal Medicine
Graduate Institute of Clinical Medicine
Dataset
Overview
Research output
(1)
Research output
Research output per year
2019
2019
2019
1
Article
Research output per year
Research output per year
1 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Filter
Article
Search results
2019
Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo
Chen, J. H., Huang, W. C., Bamodu, O. A., Chang, P. M. H.,
Chao, T. Y.
& Huang, T. H.,
Jun 27 2019
,
In:
BMC Cancer.
19
,
1
, 5811.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
Malignant Neoplasm
100%
Metastatic Breast Cancer
100%
Antibodies
100%
Monospecific Antibody
100%
Epithelial Mesenchymal Transition
100%
28
Citations (Scopus)